Categories Earnings, Finance

American Express (AXP) earnings preview: Higher revenue and profits expected in Q4

American Express Company (NYSE: AXP) is slated to report fourth quarter 2019 earnings results on Friday, January 24, before the market opens. The company is expected to report higher revenues and profits for the quarter.  

Analysts estimate earnings of $2.01 per share, which is above earnings of $1.74 per share reported a year earlier. Revenue is expected to grow more than 8% to $11.36 billion.

American Express reports Q3 2019 earnings results

The topline numbers are likely to benefit from cardmember spending and revenues from fee-based products. The results might also be helped by a growth in the small and medium-sized enterprise sector as well as in consumer spending.

Last quarter, revenue growth was driven by a balanced mix of cardmember spending, loans and membership revenues from fee-based products, which grew 19% and exceeded $1 billion for the first time. The company also added 2.9 million new proprietary card members during the period.

Also read: American Express Q3 2019 Earnings Call Transcript

In the third quarter of 2019, American Express topped revenue and earnings estimates, with revenue growing 8% to $10.99 billion and adjusted EPS increasing 11% to $2.08. The company saw revenue growth across all its segments as well.

For the fourth quarter, American Express has guided for revenue growth of 8-10%. For the full year of 2019, the company expects GAAP EPS of $7.64-8.14 and adjusted EPS of $7.85-8.35.    

Shares of American Express have gained 31% in the past one year and over 4% in the past one month. The majority of analysts have rated the stock as Buy and it has an average price target of $137.88.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top